8 common cancers could be detected early with $500 blood test

mg

A simple-to-take test that tells if you have a tumor lurking, and even where it is in your body, is a lot closer to reality—and may cost only $500.

The new test, developed at Johns Hopkins University, looks for signs of eight common types of cancer. It requires only a blood sample and may prove inexpensive enough for doctors to give during a routine physical.

The test, detailed [January 18] in the journal Science, could be a major advance for “liquid biopsy” technology, which aims to detect cancer in the blood before a person feels sick or notices a lump.

That’s useful because early-stage cancer that hasn’t spread can often be cured.

For their test, Hopkins researchers looked at blood from 1,005 people with previously diagnosed ovarian, liver, stomach, pancreatic, esophageal, colorectal, lung, or breast cancer.

Their test searches for a combination of eight cancer proteins as well as 16 cancer-related genetic mutations.

The test was best at finding ovarian cancer, which it detected up to 98 percent of the time. It correctly identified a third of breast cancer cases and about 70 percent of people with pancreatic cancer, which has a particularly grim outlook.

The chance of a false alarm was low: only seven of 812 apparently healthy people turned up positive on the test.

Read full, original post: A Cheap and Easy Blood Test Could Catch Cancer Early

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.noReviewsLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jul-6-2026-02_25_26-PM
40 million Americans take glucosamine. If you have memory loss, it could accelerate cognitive decline.
ChatGPT-Image-Jul-17-2026-12_42_10-PM
Viewpoint: RFK, Jr. is setting up a panel to compensate people who claim they were injured by a COVID vaccine–no proof needed 
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-07-17-at-12.55.22-PM
Viewpoint: Is bagged salad a dangerous science experiment? Challenging an online misinformation campaign
px-Minced-beef-meat-cow-cattle
Can we trust Trump’s USDA to accurately report farm data? Beef export numbers suggest ‘no’.
Screenshot 2026-07-11 094410
Growing animal muscle and fat cells inside rice grains and calling it beef: One of numerous genetically engineered products shaking up our ecosystem
ma art page image
‘It’s time to have a conversation’: Once adamantly opposed to human gene editing, UK’s The Guardian acknowledges likely benefits
ChatGPT-Image-Jun-17-2026-03_29_08-PM
Viewpoint: What’s the impact of the U.S. abandoning support for global health?
afb-a-b
As the EU loosens restrictions on agricultural gene editing, it remains years behind the rest of the world on equally-safe GMO foods
file-f-d-d-
Facts & Fallacies Podcast: Europe's AC debacle underscores fatal flaw in green activism
ChatGPT-Image-Jul-8-2026-12_32_48-PM
Viewpoint: SCOTUS strikes a blow against junk science in Bayer glyphosate case. Will it deter mass tort litigators?
ChatGPT-Image-Jul-9-2026-02_39_22-PM
Viewpoint: Polyphenols or NAD+ supplements to combat aging: No, Gwenyth Paltrow and followers, don’t waste your money.
Screenshot-2026-07-16-at-11.32.12-AM
Viewpoint: Trump appoints climate change hoax promoter to head influential government policy project
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.